-
AI-Based Approach Crunches Real-World Data To Emulate Clinical Trials
Clinical Research News | A computer scientist at The Ohio State University (OSU) recently demonstrated the potential of artificial intelligence to crunch real-world data and emulate randomized clinical trials, speeding the pace of drug repurposing.
Feb 2, 2021
-
23andMe Launches Severity Calculator, Middle-Aged Adults Also at Danger, High Omega-3 Index Reduces Mortality Risk: COVID-19 Updates
Clinical Research News I Cluster randomized trials could help children return safely to schools, early anticoagulation therapy does not improve outcomes, recovered patients experience lasting effects. Plus: NIH launches database to track COVID-19 related neurological symptoms and 86% of doctors believe mental health, depression will be biggest non-COVID-19 public health issue.
Jan 29, 2021
-
New DTRA Members, Veeva Now A Public Benefit Corporation, More
Clinical Research News | Strategic collaborations to enable more diverse trial populations, advance combinatorial intravesical immunotherapy, and engage patients in a privacy-centric way. Plus: new partnership program for CROs and an Oracle integration for Cognizant’s Shared Investigator Platform.
Jan 28, 2021
-
Risk Management During A Pandemic: How Pfizer’s Quality Management System Fared
Clinical Research News | Nothing quite tests a risk-based management approach like a global pandemic that few predicted. And for Pfizer’s Melissa Suprin, the COVID-19 pandemic was the first big test of the quality management system.
Jan 26, 2021
-
Five Variants of Disease, When Patient Stratification Scores Fail, Studies for Long COVID: COVID-19 Updates
Clinical Research News| The UK’s patient stratification score doesn’t hold up to scrutiny, Fauci and others encourage doctors to equip themselves to argue for vaccines, NIH launches a study of “Long COVID”, and more. Plus: Siemens, with German funding, sets up more COVID-19 treatment facilities for South Africa.
Jan 22, 2021
-
Drugs Targeting Cellular Aging May Prove Useful For Numerous Conditions
Clinical Research News | Fundamental aging processes appear to be root-cause contributors to multiple conditions, ranging from heart attacks and cancer to neurodegenerative disorders like Alzheimer’s disease. Now a series of clinical trials will look at whether senolytics— drugs targeting cellular aging—could affect many or perhaps all other aging mechanisms because they are interlinked.
Jan 21, 2021
